"Solitary fibrous tumor of pleural cavity"@en . "5"^^ . "Solit\u00E1rn\u00ED fibr\u00F3zn\u00ED tumor pleury je p\u0159ev\u00E1\u017En\u011B benign\u00ED n\u00E1dor, vych\u00E1zej\u00EDc\u00ED z mezenchym\u00E1ln\u00EDch bun\u011Bk. Malign\u00ED varianta tohoto n\u00E1doru se vyskytuje z\u0159\u00EDdka. L\u00E9\u010Dba tohoto n\u00E1doru je prim\u00E1rn\u011B chirurgick\u00E1, se snahou o radik\u00E1ln\u00ED resekci i v p\u0159\u00EDpad\u011B infiltrativn\u00EDho r\u016Fstu. Adjuvantn\u00ED l\u00E9\u010Dba je indikov\u00E1na u malign\u00EDch variant tumoru. SFT pom\u011Brn\u011B \u010Dasto recidivuj\u00ED a jejich progn\u00F3zu a riziko recidivy lze odhadnout podle morfologick\u00FDch ukazatel\u016F a stupn\u011B biologick\u00E9ho chov\u00E1n\u00ED. Retrospektivn\u00ED anal\u00FDza souboru pacient\u016F se SFT, operovan\u00FDch na pracovi\u0161ti 2006-2009. Solit\u00E1rn\u00ED fibr\u00F3zn\u00ED tumor pleury je pom\u011Brn\u011B vz\u00E1cn\u00FD n\u00E1dor z fibroblastick\u00FDch bun\u011Bk, jeho\u017E biologick\u00E1 povaha je nejist\u00E1 a stanovuje se v n\u011Bkter\u00FDch p\u0159\u00EDpadech obt\u00ED\u017En\u011B na podklad\u011B jednak imunohistochemick\u00FDch, ale i morfologick\u00FDch ukazatel\u016F. L\u00E9\u010Dba je chirurgick\u00E1 - odstran\u011Bn\u00ED n\u00E1doru do zdrav\u00E9 tk\u00E1n\u011B. Adjuvantn\u00ED terapie je indikov\u00E1na u malign\u00EDch variant n\u00E1dor\u016F. SFT pom\u011Brn\u011B \u010Dasto recidivuj\u00ED, v z\u00E1vislosti na sv\u00E9 biologick\u00E9 povaze a morfologick\u00FDch vlastnostech."@cs . . . "CZ - \u010Cesk\u00E1 republika" . . "288511" . . "4"^^ . "0035-9351" . "pleura; solitary fibrous tumor"@en . . . "Solit\u00E1rn\u00ED fibr\u00F3zn\u00ED tumor pleur\u00E1ln\u00ED dutiny" . . . . "Bohanes, Tom\u00E1\u0161" . "Solitary fibrous tumor of pleural cavity"@en . "Neoral, \u010Cestm\u00EDr" . "89" . . "Rozhledy v chirurgii" . "Solit\u00E1rn\u00ED fibr\u00F3zn\u00ED tumor pleury je p\u0159ev\u00E1\u017En\u011B benign\u00ED n\u00E1dor, vych\u00E1zej\u00EDc\u00ED z mezenchym\u00E1ln\u00EDch bun\u011Bk. Malign\u00ED varianta tohoto n\u00E1doru se vyskytuje z\u0159\u00EDdka. L\u00E9\u010Dba tohoto n\u00E1doru je prim\u00E1rn\u011B chirurgick\u00E1, se snahou o radik\u00E1ln\u00ED resekci i v p\u0159\u00EDpad\u011B infiltrativn\u00EDho r\u016Fstu. Adjuvantn\u00ED l\u00E9\u010Dba je indikov\u00E1na u malign\u00EDch variant tumoru. SFT pom\u011Brn\u011B \u010Dasto recidivuj\u00ED a jejich progn\u00F3zu a riziko recidivy lze odhadnout podle morfologick\u00FDch ukazatel\u016F a stupn\u011B biologick\u00E9ho chov\u00E1n\u00ED. Retrospektivn\u00ED anal\u00FDza souboru pacient\u016F se SFT, operovan\u00FDch na pracovi\u0161ti 2006-2009. Solit\u00E1rn\u00ED fibr\u00F3zn\u00ED tumor pleury je pom\u011Brn\u011B vz\u00E1cn\u00FD n\u00E1dor z fibroblastick\u00FDch bun\u011Bk, jeho\u017E biologick\u00E1 povaha je nejist\u00E1 a stanovuje se v n\u011Bkter\u00FDch p\u0159\u00EDpadech obt\u00ED\u017En\u011B na podklad\u011B jednak imunohistochemick\u00FDch, ale i morfologick\u00FDch ukazatel\u016F. L\u00E9\u010Dba je chirurgick\u00E1 - odstran\u011Bn\u00ED n\u00E1doru do zdrav\u00E9 tk\u00E1n\u011B. Adjuvantn\u00ED terapie je indikov\u00E1na u malign\u00EDch variant n\u00E1dor\u016F. SFT pom\u011Brn\u011B \u010Dasto recidivuj\u00ED, v z\u00E1vislosti na sv\u00E9 biologick\u00E9 povaze a morfologick\u00FDch vlastnostech." . . "Solit\u00E1rn\u00ED fibr\u00F3zn\u00ED tumor pleur\u00E1ln\u00ED dutiny"@cs . "[48892B9731EB]" . "Szkorupa, Marek" . . . "Klein, Ji\u0159\u00ED" . . "Solit\u00E1rn\u00ED fibr\u00F3zn\u00ED tumor pleur\u00E1ln\u00ED dutiny"@cs . "RIV/61989592:15110/10:10225025" . "Solit\u00E1rn\u00ED fibr\u00F3zn\u00ED tumor pleur\u00E1ln\u00ED dutiny" . . "5"^^ . . "Solitary fibrous pleural tumor (SFT) is a benign tumor arising from mesenchymal cells. A malignant version of the tumor is rare. Usually, SFT affects visceral, as well as parietal pleura, most commonly in a form of a pedunculated tumor. The treatment is primarily surgical. Adjuvant therapy is indicated in malignant varieties of the tumor. SFTs have fairly high relaps rates and their prognosis and the risk of relaps can be estimated based on morphological indicators and assessment of their biological characteristics. Retrospective analysis of SFT group of patients, who were operated from 2006 to 2009. The treatment is surgical - removal of the tumor as far as the healthy tissue. Adjuvant therapy is indicated in malignant varieties of the tumor. SFT relaps rate is fauly high, depending on the tumor biological characteristics and its morphological features."@en . "12" . . "RIV/61989592:15110/10:10225025!RIV12-MSM-15110___" . "15110" . "Chud\u00E1\u010Dek, Josef" . "I" .